World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
6932
World Ranking
4640
National Ranking
2089

Michael J. Gough publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael J. Gough sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 176 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael J. Gough D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael J. Gough sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings.

    Rosamonde E. Banks;Michael J. Dunn;Mary A. Forbes;Anthea Stanley

  • Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.

    Kristina H. Young;Jason R. Baird;Talicia Savage;Benjamin Cottam

  • Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.

    David J. Messenheimer;Shawn M. Jensen;Michael E. Afentoulis;Keith W. Wegmann

  • Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

    Jason R. Baird;David Friedman;Benjamin Cottam;Thomas W. Dubensky

  • OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor.

    Michael J. Gough;Carl E. Ruby;William L. Redmond;Birat Dhungel

  • TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking.

    Andrew J Gunderson;Tomoko Yamazaki;Kayla McCarty;Nathaniel E Fox

  • Role of the immunosuppressive microenvironment in immunotherapy.

    Garth W. Tormoen;Marka R. Crittenden;Michael J. Gough

  • Facets of heat shock protein 70 show immunotherapeutic potential

    Stephen M Todryk;Michael J Gough;A Graham Pockley

  • Apoptosis or necrosis for tumor immunotherapy: what's in a name?

    Alan Melcher;Michael Gough;Stephen Todryk;Richard Vile

  • Signaling through OX40 enhances antitumor immunity.

    Shawn M. Jensen;Levi D. Maston;Michael J. Gough;Carl E. Ruby

  • Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

    Michael J. Gough;Marka R. Crittenden;Maryclare Sarff;Puiyi Pang

  • Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.

    Rom Leidner;Marka Crittenden;Kristina Young;Hong Xiao

  • Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

    Andrew J Gunderson;Venkatesh Rajamanickam;Cynthia Bui;Brady Bernard

  • Viral Fusogenic Membrane Glycoproteins Kill Solid Tumor Cells by Nonapoptotic Mechanisms That Promote Cross Presentation of Tumor Antigens by Dendritic Cells

    Andrew R. Bateman;Kevin J. Harrington;Tim Kottke;Atique Ahmed

  • Macrophages Orchestrate the Immune Response to Tumor Cell Death

    Michael J. Gough;Alan A. Melcher;Atique Ahmed;Marka R. Crittenden

  • A simple method to cure established tumors by inflammatory killing of normal cells.

    Gregory A Daniels;Luis Sanchez-Perez;Rosa Maria Diaz;Timothy Kottke

  • A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

    Todd Crocenzi;Benjamin Cottam;Pippa Newell;Ronald F. Wolf

  • Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.

    Marka R Crittenden;Lauren Zebertavage;Gwen Kramer;Shelly Bambina

  • Cells as vehicles for cancer gene therapy: The missing link between targeted vectors and systemic delivery?

    Kevin Harrington;Luis Alvarez-Vallina;Marka Crittenden;Michael Gough

  • Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy

    Marka R. Crittenden;Benjamin Cottam;Talicia Savage;Cynthia Nguyen

Frequent Co-Authors

Richard G. Vile
Richard G. Vile Mayo Clinic
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Alan Melcher
Alan Melcher Institute of Cancer Research
David Friedman
David Friedman Columbia University
Andrew D. Weinberg
Andrew D. Weinberg Providence Portland Medical Center
Atique U. Ahmed
Atique U. Ahmed Northwestern University
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Marion K Campbell
Marion K Campbell University of Aberdeen
Jill J Francis
Jill J Francis University of Melbourne
Walter J. Urba
Walter J. Urba Providence Portland Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to various healthcare and research careers, many of which benefit from advanced nursing roles. For those interested in mental health, exploring top psychiatric mental health nurse practitioner programs online can be a strategic choice, offering comprehensive clinical placements that support expertise in patient care.

Affordability is also a significant factor. Students may consider options like the cheapest online pmhnp programs to balance education quality with cost-effectiveness, making advanced degrees accessible without excessive financial burden.

Understanding career prospects is crucial, particularly when evaluating advanced nursing degrees. The how much does a dnp make resource highlights earning potential across the U.S., helping graduates make informed decisions about their professional pathways.

For nurses aiming to specialize further, programs focusing on transitions, such as the fnp to acnp bridge program online, offer flexible options to advance into acute care roles. This pathway is ideal for those seeking to expand their scope of practice within immunology-related healthcare settings.

Best Scientists Citing Michael J. Gough

Trending Scientists

Recently Published Articles